What we found on the web about Adalimumab
Adalimumab - Wikipedia, the free encyclopedia
Adalimumab (HUMIRA, Abbott) is the third TNF inhibitor, after infliximab and etanercept, to be approved in the United States. Like infliximab and etanercept, adalimumab binds to ...
Infliximab - Wikipedia, the free encyclopedia
Adalimumab; Biological therapy for inflammatory bowel disease; Etanercept; Monoclonal antibody; Tumor necrosis factors External links. National Rheumatoid Arthritis Society (NRAS) ...
Adalimumab (Humira)
Policy. Aetna considers adalimumab (Humira) medically necessary for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage ...
CCFA.org: Adalimumab may maintain remission in severe Crohn's disease
Home \ Reuters \ Adalimumab may maintain remission in severe Crohn's disease Adalimumab may maintain remission in severe Crohn's disease Last updated: February 20, 2007
Humira - Adalimumab - Dosage - Side Effects - Interactions - Warnings
Humira (adalimumab) drug information, dosage, side effects, drug interactions, and warnings. Humira, generic drug name adalimumab, is a TNF blocker drug classified as a biologic ...
arc :: Drug information: Adalimumab
Adalimumab (brand name Humira) is a type of drug known as anti-TNF. In people with rheumatoid arthritis and some other inflammatory diseases a protein called TNF is present in the ...
Adalimumab: Drug Information Provided by Lexi-Comp: Merck Manual ...
This information has been developed and provided by an independent third-party source. Merck & Co., Inc. does not endorse and is not responsible for the accuracy of the content, or ...
Adalimumab
Adalimumab is a prescription medicine that is approved to treat certain inflammatory conditions. This eMedTV page explains how this drug works to relieve symptoms of these ...
Adalimumab SubQ : Uses, Side Effects, Interactions, Pictures, Warnings ...
Find patient medical information for Adalimumab SubQ on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Adalimumab

Adalimumab (HUMIRA, Abbott) is the third TNF inhibitor, after infliximab and etanercept, to be approved in the United States. Like infliximab and etanercept, adalimumab binds to TNFα, preventing it from activating TNF receptors; adalimumab was constructed from a fully human monoclonal antibody, while infliximab is a mouse-human chimeric antibody and etanercept is a TNF receptor-IgG fusion protein. TNFα inactivation has proven to be important in downregulating the inflammatory reactions associated with autoimmune diseases. As of 2008 adalimumab has been approved by the FDA for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Adalimumab
Revolutionary New Treatment for Sciatica Advances in the Clinic
PRWeb
The efficacy and safety of caudal epidural injection with the TNF-antagonist, adalimumab and etanercept, in patients with disc-herniation-induced sciatica. Results of a randomized, controlled, 1-month follow-up study., in Proceedings of the...